Chromosomal aberrations in nasopharyngeal carcinoma analyzed by comparative genomic hybridization

Genes Chromosomes and Cancer

Volumn 25, Issue 2, 1999, Pages 169-175

  Chen, Yann Jang ^a   Ko, Jenq Yuh ^b   Chen, Pei Jer ^c   Shu, Chih Hung ^a   Hsu, Ming Ta ^a   Tsai, Shih Feng ^a   Lin, Chi Hung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER STAGING; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RECURRENT CANCER; SUPERNUMERARY CHROMOSOME;

EID: 84984538774     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199906)25:2<169::AID-GCC13>3.0.CO;2-I     Document Type: Article

References (41)

1. Chen CJ, Liang KY, Chang YS, Wang YF, Hsieh T, Hsu MM, Chen JY, Liu MY. 1990. Multiple risk factors of nasopharyngeal carcinoma: Epstein-Barr virus, malarial infection, cigarette smoking and familial tendency. Anticancer Res 10:547-553.
2. Cheng RYS, Lo KW, Huang DP, Tsao SW. 1997. Loss of heterozygosity on chromosome 14 in primary nasopharyngeal carcinoma. Int J Oncol 10:1047-1050.
3. Cheng Y, Poulos NE, Lung ML, Hampton G, Ou B, Lerman MI, Stanbridge EJ. 1998. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proc Natl Acad Sci USA 95:3042-3047.
4. Department of Health, Executive Yuan, Republic of China. 1998. Annual Report of Cancer Registration: Taiwan Area in 1996.
5. du Manoir S, Schrock E, Bentz M, Speicher MR, Joos S, Ried T, Lichter P, Cremer T. 1995. Quantitative analysis of comparative genomic hybridization. Cytometry 19:27-41.
6. Forozan F, Karhu R, Kononen J, Kallioniemi A, Kallioniemi OP. 1997. Genome screening by comparative genomic hybridization. Trends Genet 13:405-409.
7. Gonzalez MV, Pello MF, Lopez-Larrea C, Suarez C, Menendez MJ, Goto E. 1997. Deletion and methylation of the tumour suppressor gene p16/CDKN2 in primary head and neck squamous cell carcinoma. J Clin Pathol 50:509-512.
8. Gronwald J, Storkel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt G, Jauch A, Lubinski J, Cremer T. 1997. Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 57:481-487.
9. Hu LF, Eiriksdottir G, Lebedeva T, Kholodniouk I, Alimov A, Chen F, Luo Y, Zabarovsky ER, Ingvarsson S, Klein G, Ernberg I. 1996. Loss of heterozygosity on chromosome arm 3p in nasopharyngeal carcinoma. Genes Chromosomes Cancer 17:118-126.
10. Huang DP, Lo KW, van Hasselt CA, Woo JK, Choi PH, Leung SF, Cheung ST, Cairns P, Sidransky D, Lee JG. 1994. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54:4003-4006.
11. Hui AB, Lo KW, Leung SF, Choi PH, Fong Y, Lee JG, Huang DP. 1996. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56:3225-3229.
12. Jessup JM, Gallick GE. 1992. The biology of colorectal carcinoma. Curr Prob Cancer 16:261-328.
13. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman FM, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
14. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
15. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F. 1995. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12:213-219.
16. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. 1998. DNA copy number amplifications in human neoplasms. Am J Pathol 152:1107-1123.
17. Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S. 1997. 17q12-21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 20:38-43.
18. Kristensen M, Quek HH, Chew CT, Chan SH. 1991. A cytogenetic study of 74 nasopharyngeal carcinoma biopsies. Ann Acad Med Singapore 20:597-600.
19. Lin T, Hsu M, Chen K, Chiang T, Jung P, Hirayama T. 1971. Mobidity and mortality of cancer of the nasopharynx in Taiwan. Gann Monogr 10:137-144.
20. Lo KW, Huang DP, Lau KM. 1995. p16 gene alterations in nasopharyngeal carcinoma. Cancer Res 55:2039-2043.
21. Lothe RA, Karhu R, Mandahl N, Mertens F, Saeter G, Heim S, Borresen-Dale AL, Kallioniemi OP. 1996. Gain of 17q24-qter detected by comparative genomic hybridization in malignant tumors from patients with von Recklinghausen's neurofibromatosis. Cancer Res 56:4778-4781.
22. Mahlamaki EH, Hoglund M, Gorunova L, Karhu R, Dawiskiba S, Andren-Sandberg A, Kallioniemi OP, Johansson B. 1997. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 20:383-391.
23. Mitelman F, Mark-Vendel E, Mineur A, Giovanella B, Klein G. 1983. A 3q + marker chromosome in EBV-carrying nasopharyngeal carcinomas. Int J Cancer 32:651-655.
24. Mostert MM, van de Pol M, van Echten J, Olde Weghuis D, Geurts van Kessel A, Oosterhuis JW, Looijenga LH. 1996. Fluorescence in situ hybridization-based approaches for detection of 12p overrepresentation, in particular i(12p), in cell lines of human testicular germ cell tumors of adults. Cancer Genet Cytogenet 87:95-102.
25. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, Baffa R, Huebner K, Croce CM. 1996. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res 56:3173-3179.
26. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. 1996. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597.
27. Pearson GR, Johansson B, Klein G. 1978. Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma. Int J Cancer 22:120-125.
28. Pearson GR, Weiland LH, Neel HB, Taylor W, Earle J, Mulroney SE, Goepfert H, Lanier A, Talvot ML, Pilch B, Goodman M, Huang A, Levine PH, Hyams V, Moran E, Henle G, Henle W. 1983. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 51:260-267.
29. Pearson GR, Neel HB I, Weiland LH, Mulroney SE, Taylor W, Goepfert H, Huang A, Levine P, Lanier A, Pilch B, Goodman M. 1984. Antibody-dependent cellular cytotoxicity and disease course in North American patients with nasopharyngeal carcinoma: a prospective study. Int J Cancer 33:777-782.
30. Plantaz D, Mohapatra G, Matthay KK, Pellarin M, Seeger RC, Feuerstein BG. 1997. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am J Pathol 150:81-89.
31. Porter MJ, Field JK, Leung SF, Lo D, Lee JC. Spandidos DA, van Hasselt CA. 1994. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. Acta Oto-Laryngol 14:105-109.
32. Ried T, Just KE, Holtgreve-Grez H, du Manoir S, Speicher MR, Schrock E, Latham C, Blegen H, Zetterberg A, Cremer T. 1995. Comparative genomic hybridization of formalin-fixed, paraffin-embedded breast tumors reveals different patterns of chromosomal gains and losses in fibroadenomas and diploid and aneuploid carcinomas. Cancer Res 55:5415-5423.
33. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
34. Schwendel A, Langreck H, Reichel M, Schrock E, Ried T, Dietel M, Petersen I. 1997. Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterations. Int J Cancer 74:86-93.
35. Shanmugaratnam K, Sobin L. 1978. Histological typing of upper respiratory tract tumors. Int Typ Tumors 19:32-33.
36. Sun Y, Hildesheim A, Lanier AE, Cao Y, Yao KT, Raab-Traub N, Yang CS. 1995. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas. Oncogene 10:785-788.
37. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM. 1996. FHIT gene alterations in head and neck squamous cell carcinomas. Proc Natl Acad Sci USA 93:9770-9775.
38. Waghray M, Parhar RS, Taibah K, al-Sedairy S. 1992. Rearrangements of chromosome arm 3q in poorly differentiated nasopharyngeal carcinoma. Genes Chromosomes Cancer 4:326-330.
39. Willem P, Mendelow B. 1997. 12p rearrangement and DNA amplification mapped by comparative genomic hybridization in a patient with secondary myeloid leukemia. Cancer Genet Cytogenet 99:30-37.
40. Wu SB, Hwang SJ, Chang AS, Hsieh T, Hsu MM, Hsieh RP, Chen CJ. 1989. Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res 9:1649-1653.
41. Zhang EP, Lian PG, Cai KL, Chen YF, Cai MD, Zheng XF, Guang XX. 1989. Radiation therapy of nasopharyngeal carcinoma: prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys 16:301-305.